Screener
ANI Pharmaceuticals ANIP Raw materials
Raw materials at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryRawMaterials.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's raw materials?
- ANI Pharmaceuticals (ANIP) reported raw materials of $77.77M in Q2 2026.
- How has ANI Pharmaceuticals's raw materials changed year-over-year?
- ANI Pharmaceuticals's raw materials increased by 21.8% year-over-year, from $63.85M to $77.77M.
- What is the long-term trend for ANI Pharmaceuticals's raw materials?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's raw materials has grown at a 7.5% compound annual growth rate (CAGR), from $67.73M to $84.11M.
- What does raw materials mean?
- Unprocessed materials and components purchased for use in manufacturing, valued at cost.
Ask your AI about ANI Pharmaceuticals's raw materials.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude